Nonalcoholic steatohepatitis in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 30, Issue 1, 2000, Pages 48-53

  Rashid, Mohsin ^b   Roberts, Eve A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b IWK Grace H C Children W/F   (Canada)

Author keywords

Acanthosis nigricans; Fatty liver Fibrosis; Obesity; Steatohepatitis

Indexed keywords

AMINOTRANSFERASE;

ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; LIVER BIOPSY; MALE; OBESITY; PRIORITY JOURNAL;

ACANTHOSIS NIGRICANS; ADOLESCENT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOPSY; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FATTY LIVER; FEMALE; HEPATOMEGALY; HUMANS; LIPIDS; LIVER; MALE; OBESITY; PROSPECTIVE STUDIES; SPLENOMEGALY;

EID: 0034046521     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200001000-00017     Document Type: Article

References (39)

1. Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis: Mayo Clinic experience with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
2. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811-6.
3. Diehl AM, Goodman Z, Ishak KG. Alcohol-like disease in nonalcoholics. Gastroenterology 1988;95:1056-62.
4. Lee RG. Nonalcoholic steatohepatitis: A study of 49 patients. Hum Pathol 1989;20:594-8.
5. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990;12:1106-10.
6. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis 1986;8:283-6.
7. Alvarez SZ, Billote J, Ongkingco-Obillos C. Chronic hepatitis with fatty change. J Gastroenterol Hepatol 1990;5:223-7.
8. Bacon BR, Farahwash MJ, Lanney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994;107:1103-9.
9. Moran JR, Ghishan FK, Halter SA, Greene HL. Steatohepatitis in obese children: A cause of chronic liver dysfunction. Am J Gastroenterol 1983;78:374-7.
10. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984;3:408-14.
11. Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vincenzo A. Persistent hypertransaminasemia resolving after weight reduction in obese children. J Pediatr 1994;125:239-41.
12. Baldridge AD, Perez-Atayde AR, Grame-Cooke F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: A multicenter retrospective study. J Pediatr 1995;127:700-4.
13. Tazawa Y, Noguchi H, Nishiomiya F, Takada G. Serum alanine aminotransferase activity in obese children. Acta Paediatr 1997; 86:238-41.
14. Bergomi A, Lughetti L, Corciulo N, et al. Italian multicenter study on liver damage in pediatric obesity (abstract). Int J Obes Relat Metab Disord 1998;22(suppl 4):S22.
15. Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children: Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997;42:1428-32.
16. Tominaga K, Kurata JH, Chen YK, et al. Prevalence of fatty liver in Japanese children and relationship to obesity: An epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002-9.
17. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.
18. Propst A, Propst T, Judmaier G, Vogel W. Prognosis in nonalcoholic steatohepatitis. Gastroenterology 1995;108:1607.
19. Brockow K, Steinkraus V, Rinninger F, Abeck D, Ring J. Acanthosis nigricans: A marker for hyperinsulinemia. Pediatr Dermatol 1995;12:323-6.
20. Stuart CA, Gilkison CR, Smith MM, Bosma AM, Keenan BS, Nagamani M. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr (Phila) 1998;37:73-9.
21. Richards GE, Cavallo A, Meyer WJ, et al. Obesity, acanthosis nigricans, insulin resistance and hyperandrogenemia: Pediatric perspective and natural history. J Pediatr 1985;107:893-7.
22. Green JS, Parfrey PS, Harnett JD, et al. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med 1989;321:1002-9.
23. Dyer DS, Wilson ME, Small KW, Pai GS. Alström syndrome: A case misdiagnosed as Bardet-Biedl syndrome. J Pediatr Ophthalmol Strabismus 1994;31:272-4.
24. Connolly MB, Jan JE, Couch RM, Wong LTK, Dimmick JE, Rigg JM. Hepatic dysfunction in Alström disease. Am J Med Genet 1991;40:421-4.
25. Boor R, Herwig J, Schrezenmeir J, Pontz BF, Schönberger W. Familial insulin resistant diabetes associated with acanthosis nigricans, polycystic ovaries, hypogonadism, pigmentary retinopathy, labyrinthine deafness, and mental retardation. Am J Med Genet 1993;45:649-53.
26. Wanless IR, Bargman JM, Oreopoulos DG, Vas SI. Subcapsular steatonecrosis in response to peritoneal insulin delivery: A clue to the pathogenesis of steatonecrosis in obesity. Mod Pathol 1989;2: 69-74.
27. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. Insulin resistance of puberty: A defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991;72: 277-82.
28. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996;39:1489-97.
29. Jiang X, Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Jr, Berenson GS. Racial (black-white) differences in insulin secretion and clearance in adolescents: The Bogalusa Heart Study. Pediatrics 1996;97:357-60.
30. Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr 1997;31:317-21.
31. Attia N, Tamborlane WV, Heptulla R, et al. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 1998;83:1467-71.
32. George DK, Goldwurm S, MacDonald GA, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-8.
33. Czaja AJ. Frequency and significance of phenotypes for alpha1-antitrypsin deficiency in type 1 autoimmune hepatitis. Dig Dis Sci 1998;43:1725-31.
34. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128-33.
35. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
36. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990;99: 1408-13.
37. Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: A follow-up study. Hepatology 1995;22:1714-9.
38. Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study. Hepatology 1996;23:1464-7.
39. Lavine JE. Treatment of obesity-induced steatohepatitis with vitamin E (abstract). Gastroenterology 1998;114:A1284-5.